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Inﬂuenza virus
Vaccinia virusPreviously we showed that the cellular protein P58IPK contributes to viral protein synthesis by decreasing the
activity of the anti-viral protein, PKR. Here, we constructed a mathematical model to examine the P58IPK
pathway and investigated temporal behavior of this biological system. We ﬁnd that inﬂuenza virus infection
results in the rapid activation of P58IPK which delays and reduces maximal PKR and eIF2α phosphorylation,
leading to increased viral protein levels. We conﬁrmed that the model could accurately predict viral and host
protein levels at extended time points by testing it against experimental data. Sensitivity analysis of relative
reaction rates describing P58IPK activity and the downstream proteins through which it functions helped
identify processes that may be the most beneﬁcial targets to thwart virus replication. Together, our study
demonstrates how computational modeling can guide experimental design to further understand a speciﬁc
metabolic signaling pathway during viral infection in a mammalian system.Cancer Center, University of
1550 NW 10th Ave., Miami, FL
odman).
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Every year the inﬂuenza virus infects millions of people worldwide.
While the vast majority of infections do not result in death, highly
virulent inﬂuenza strains can evolve into global pandemics that
dramatically increase incidence of mortality. Recent emergence of
inﬂuenza viruses resistant to ribavirin and oseltamvir (Regoes and
Bonhoeffer, 2006) further demonstrates the need for better therapeutics
against inﬂuenza virus infection.Mathematicalmodels of inﬂuenza virus
infection can illustrate howcellular factors affect virulence,which in turn
can identify new therapeutic targets tomodulate the impact of the virus.
During infection, inﬂuenzavirus abrogates cellularmRNAtranslation
and facilitates viral mRNA translation (Garﬁnkel and Katze, 1992). The
host cell utilizes multiple mechanisms to prevent translation of viral
transcripts, such as the interferon-induced activation of PKR. PKR is a
dsRNA-activated protein kinase that phosphorylates the alpha subunit
of eukaryotic translation initiation factor 2 (eIF2α), thereby inhibiting
protein synthesis (Dever, 2002). To evade this inhibition response,inﬂuenza virus has the capacity to limit PKR activation by activating the
host cell protein P58IPK, a cellular inhibitor of PKR (Lee et al., 1992).
P58IPK's ability to regulate and prevent the phoshorylation of eIF2α
activity signiﬁes that P58IPK is a critical component of cellular and viral
mRNA translation.
Recently we demonstrated that inﬂuenza virus mRNA translation
becomes less efﬁcient in the absence of P58IPK, using mutant mouse
embryonic ﬁbroblasts (MEFs) lacking P58IPK (Goodman et al., 2007).
Thesemeasurements suggested that increased PKRactivation andeIF2α
phosphorylation decreased the mRNA translation efﬁciency. Here we
create a mathematical model to probe potential interactions among
these proteins, extending our previous experimental work and
enhancing our understanding of dynamic behavior among proteins in
this viral replication pathway. We used previous experimental data to
construct our model, both in structure and in speciﬁc parameter values.
We performed additional experiments to conﬁrm the structure of the
model and test its predictions. Furthermore, we were able to use the
model to simulate conditionsnot readily tested in the laboratory, suchas
inhibition of the PKR-speciﬁc effects due to P58IPK. Because P58IPK also
becomes activated during ER stress (Liu and Kaufman, 2003), this
mathematical model provides a useful structure for incorporating other
P58IPK-activating stimuli, merging the dynamic responses of viral
infectionwith theunfoldedprotein response or other pathways through
which P58IPK functions. Similarly, themodel also provides a platform for
testing other PKR inhibitors to study how PKR kinetics respond to a
variety of infection systems, making this model a relevant tool for cell
biologists and virologists alike.
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Model development
This study focuses on the role of P58IPK during virus infection,
exploring the mechanisms through which P58IPK regulates eIF2α
phosphorylation. The initial model structure was based on a simpliﬁed
conceptual model presented by Goodman et al. (2007) that included
two eIF2α kinases, PKR and PERK. Subsequently we removed the PERK
kinase, as it is not activated by inﬂuenza virus infection (Goodman et al.,
2007) (Goodman and Katze, unpublished data), nor does our model
include an ER stress stimulus to activate the PERK kinase. We arrived at
the current model structure (Fig. 1), described by ﬁve ordinary
differential equations (ODEs), where t is time:
dP58a tð Þ
dt
= rP58;12 Flu tð Þð Þ P58 total−P58a tð Þð Þ−rP58;21 P58a tð Þð Þ ð1Þ
dPKRP tð Þ
dt
= rPKR;12;Flu Flu tð Þð Þ PKR total−PKRP tð Þð Þ−rPKR;21;P58 P58a tð Þð Þ
PKRP tð Þð Þ−rPKR;21;NS1 NS1 tð Þð Þ PKRP tð Þð Þ ð2Þ
deIF2αP tð Þ
dt
= reIF2α;12 eIF2α total−eIF2αP tð Þð Þ PKRP tð Þð Þ−reIF2α;21
eIF2αP tð Þð Þ ð3Þ
dFlu tð Þ
dt
= rFlu Flu tð Þð Þ 1−
Flu tð Þ
K
 
ð4Þ
dNS1 tð Þ
dt
= rNS1 Flu tð Þð Þ eIF2α total−eIF2αP tð Þð Þ−rPKR;21;NS1 NS1 tð Þð Þ
PKRP tð Þð Þ
ð5Þ
In the model P58a represents activated P58IPK protein; PKRP
phosphorylated, activated PKR protein; eIF2αP phosphorylated,
inactive eIF2α protein; Flu the overall level of infection within the
host cell; and NS1 inﬂuenza NS1 protein. In the model we have
represented key enzymatic reactions and cellular processes of the
P58IPK pathway relevant to inﬂuenza infection. First inﬂuenza virus
activates P58IPK (Eq. (1)) (Lee et al., 1992). Secondly inﬂuenza virus
also activates PKR(Eq. (2)), leading to PKR phosphorylation (DeyFig. 1. Schematic of model. Flu, which grows logistically as described in Eq. (4), infects a
cell and activates PKR at a rate of rPKR,12,Flu and activates P58 at a rate of rP58,12. Active P58
(P58a) inhibits active PKR (PKRP) at a rate of rPKR,21,P58, while NS1, which is synthesized
in the presence of Flu and unphosphorylated eIF2α at a rate of rNS1, inhibits PKRP at a
rate of rPKR,21,NS1. P58a is deactivated at an intrinsic rate of rP58,21. PKRP phosphorylates
eIF2α at a rate of reIF2α,12, while dephosphorylation of eIF2αP occurs at a rate of reIF2α,21.
Equations and more detail are given in the text.et al., 2005), while active P58IPK (P58a) and NS1 increase PKR
deactivation (Lu et al., 1995). Phosphorylated PKR is not deactivated
by the enzymatic reaction phosphorylating eIF2α (Eq. (3)) (Dey et al.,
2005). The level of inﬂuenza virus increases logistically, with carrying
capacity, K (Eq. (4)). NS1 is synthesized in the presence of eIF2α and
inﬂuenza virus, but is consumed in the PKR deactivation reaction, as
NS1 binds dsRNA, which is synthesized as an intermediate of viral
genome replication and is the substrate which normally activates PKR
(Dey et al., 2005). We assume no natural degradation of proteins over
the timecourse of the model. The model presented here assumes that
the total concentration of any host protein is constant, with the sum of
the active and inactive states equaling the total (e.g., P58_total=P58a
(t)+P58(t)). We then derived parameter values (Table 1) for the
model as described in the Methods section. Brieﬂy parameter values
were derived either from known values in the experimental literature
or from optimizing the ﬁt of the model to a set of previously observed
early time-point time courses (Goodman et al., 2007). These viral
infections were performed in two cell lines, wild-type (P58IPK+/+)
and P58IPK−/− mouse embryonic ﬁbroblasts (MEFs), with observa-
tions made at 6–9 h post-infection. We used these experimental data
as a training set, reserving other, newly obtained experimental data as
a test set (described below). After ﬁtting the model to the training set,
model output agreed well with experimental data points for
phosphorylated PKR, phosphorylated eIF2α, and NS1. Overall correla-
tion coefﬁcients (Pearson) between output and experimental data were
0.95 and0.91 for experiments performed in thepresence (P58IPK+/+) and
absence (P58IPK−/−) of P58IPK, respectively (Fig. 2). As a negative control,
we simulated the absence of inﬂuenza infection (Flu(0)=0), and the
model displayed the expected behavior, with no activation of any of the
cellular proteins andno change in inﬂuenzavirus levels (datanot shown).Simulations predict faster activation of PKR and eIF2α phosphorylation
with decreased NS1 synthesis in the absence of P58IPK
Model predictions for PKR and eIF2α phosphorylation follow
measured biological trends in the absence and presence of P58IPK at
6–9 hpost-infection (Fig. 2). Themodel output alsoprovides an indication
of what happens within inﬂuenza virus-infected cells at shorter timeTable 1
Model parameters and initial conditions.
Symbol Meaning Value (reference)
rPKR,12,Flu Rate of influenza virus-mediated PKR phosphorylation 0.1263 PFU
-1
•h-1
rPKR,21,P58 Rate of P58
IPK-mediated PKR inhibition 0.3 nM-1•h-1
(Lee et al., 1994b)
rPKR,21,NS1 Rate of NS1-mediated PKR inhibition 0.025 nM
-1
•h-1
(Lu et al., 1995)
rP58,12 Rate of influenza virus-mediated P58
IPK activation 0.0879 PFU-1•h-1
rP58,21 Rate of P58
IPK deactivation 0.052 h-1
reIF2a,12 Rate of PKR-mediated eIF2α phosphorylation 0.0793 nM
-1
•h-1
reIF2a,21 Rate of eIF2α dephosphorylation 0.0243 h
-1
rFlu Rate of influenza virus growth 0.075 h-1
(Borland and 
Mahy, 1968)
rNS1 Rate of NS1 growth 0.05 PFU-1•h-1
(Lamb et al., 2001)
K Cell’s carrying capacity of influenza virions 100 PFU (Goodman
et al., 2010)
PKR_total Initial concentration of all PKR species 2 nM
PKRP(0) Initial concentration of phosphorylated PKR 0 nM
P58_total Initial concentration of all P58IPK  species (wild-type) 10 nM
P58a(0) Initial concentration of active P58IPK (wild-type) 0 nM
eIF2α_total Initial concentration of all eIF2α species 2 nM
eIF2αP(0) Initial concentration of phosphorylated eIF2α 0 nM
Flu(0) Initial dose of influenza virus 5 PFU
NS1(0) Initial concentration of influenza NS1 protein 0 nM
Highlighted parameters were determined by the Nelder–Mead optimization algorithm
described in the Methods section.
Fig. 2. Dynamics of PKR and eIF2α phosphorylation in the presence and absence of P58IPK
during inﬂuenza virus infection. Model results simulate (sim) the predicted timecourses
for PKR phosphorylation (A), eIF2α phosphorylation (B), and NS1 synthesis (C) over the
ﬁrst 10 h post-infection, in the presence (black lines) or absence of P58IPK (grey lines). The
data arenormalizedand representedasarbitraryunits. Experimental (exp)data (replotted
from Figs. 2 and 3 (Goodman et al., 2007), Copyright ©American Society forMicrobiology,
Journal of Virology, Vol. 81, p. 2221–2230, 2007) are shown at discrete timepoints with
black or grey boxes.
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phosphorylated in the absence of P58IPK up to 4 h post-infection (Fig. 2A),
at which point it reaches stable, maximal activation. In contrast, in the
presence of P58IPK, PKR phosphorylation increases until 1 h p.i, then
decays brieﬂy due to increased P58IPK activation and slowly increases
thereafter. EIF2α phosphorylation (Fig. 2B) lags PKR phosphorylation,
with eIF2α phosphorylation developing more slowly in the presence of
P58IPK. EIF2α phosphorylation inhibits initiation of translation (Dever,
2002), leading to an inverse correlation between levels of eIF2α
phosphorylation and viral protein synthesis. Simulation results conﬁrm
this correlation, followingmeasured biological trends for NS1 synthesis in
the presence and absence of P58IPK (Fig. 2C).
Preliminary model predictions showed intriguing behavior at
longer time points, prompting us to perform inﬂuenza virus infections
in P58IPK−/− and P58IPK+/+ MEFs to examine longer timepoints post-
infection. With these data, we could generate a test set of biologicaldata for comparison with predicted behavior from the simulations. As
a result, we infected P58IPK−/− and P58IPK+/+ MEFs with inﬂuenza
virus for 24, 48, and 72 h and subsequently determined levels of NS1,
PKR phosphorylation, and eIF2α phosphorylation (Fig. 3A). Quanti-
ﬁcation of the results from three independent experiments consti-
tuted our test set of data. Correlation coefﬁcients among the test set of
biological data and simulation results were 0.96 and 0.95 in the
presence and absence of P58IPK, respectively (Figs. 3B–D).
After testing the model on the experimental data at 24–72 h post-
infection, we then used the model to make predictions of and gain
insight into the longer-term behavior of the biological system. We
calculated the steady-state solution of the model analytically, and
upon substituting the optimized parameter set, we derived the
steady-state values and time to reach steady-state (Table 2). Other
solutions in which parameter values reached zero were disregarded,
as this was not observed experimentally. Longer-term simulations
showed that PKR phosphorylation occurs more slowly in the presence
of P58IPK, reaching steady-state at 56 h (Fig. 3B). In addition, steady-
state PKR phosphorylation is ~25% less in the presence of P58IPK than
in its absence. In the presence of P58IPK, PKR phosphorylation reaches
steady-state 10 h before eIF2α phosphorylation (Fig. 3C). In the
absence of P58IPK, however, the kinetics of eIF2α phosphorylation lag
PKR phosphorylation. Steady-state values for eIF2α phosphorylation
show a minimal difference between the two genotypes, suggesting
that other eIF2α kinases, such as PERK, GCN2, and HRI, may be
phosphorylating eIF2αwhile P58IPK is inhibiting PKR-mediated eIF2α
phosphorylation. We observed that NS1 synthesis reaches steady-
state faster in the absence of P58IPK. However, for both conditions, the
time at which NS1 synthesis reaches steady-state lags the times at
which PKR and eIF2α phosphorylation reach steady-state. By steady-
state, the level of NS1 synthesis is 150% greater in the presence of
P58IPK than in its absence, suggesting that P58IPK may function to
promote long-term viral replication in inﬂuenza virus-infected cells.
Together, these extended timecourse simulations provide new data
about the equilibrium states of the proteins described in the model
and the window of time when the proteins become rapidly activated,
a period that may be beneﬁcial to target the proteins for potential
therapeutic intervention.
Even though there was strong correlation between our optimized
parameter set and the test set of biological data, we next investigated
the uniqueness of the optimized parameter set by comparing it to a
parameter set generated by rigorously ﬁtting the simulated data to all
of the biological data.With a larger set of biological data, we could also
generate more robust statistics associated with the ﬁtted parameter
set. These parameters are shown in Table 3, along with their
covariances and conﬁdence intervals. The correlation coefﬁcients
between all biological data and simulated data remain high (0.95 for
P58IPK−/− and 0.97 for P58IPK+/+). The major difference in this
parameter set as compared to the previously optimized set is with
regard to P58IPK activation. With this parameter set, we observed a
greater rate of P58IPK deactivation, although its covariance and
conﬁdence intervals are high. However, both parameter sets generate
simulation curves that follow the same trends. Together, these results
suggest that both sets of parameter estimates were non-unique and
can be used for further analysis of the model. Since the second
parameter set was generated by ﬁtting the simulated data with all of
the biological results, and the parameter intervals for the simulated
data overlap with most biological results (Fig. 4), subsequent analysis
of P58IPK activation and model sensitivity were performed using the
optimized parameters in Table 3.
Using the parameter set derived using all of the biological data, we
next examined the kinetics of P58IPK activation. In contrastwith the PKR
and eIF2α phosphorylation responses and NS1 synthesis, there are no
published data on P58IPK activation rates during viral infection. This rate
is difﬁcult to measure in the laboratory because P58IPK becomes
activated during inﬂuenza virus infection following dissociation from
Fig. 3. Dynamics of PKR and eFI2α phosphorylation and NS1 synthesis for long-sustained times post-infection. P58IPK−/− and P58IPK+/+ MEFs were mock-infected (M) or infected
with the WSN strain of inﬂuenza virus at 1 PFU/cell for 24, 48, or 72 h. The levels of inﬂuenza virus NS1, phosphorylated PKR and eIF2α, total PKR and eIF2α, and actin were
determined by immunoblot analysis (A). Densitometry analysis (mean pixel value multiplied by total pixels) of three independent experiments was performed to determine the
relative levels of NS1, phosphorylated PKR, and phosphorylated eIF2α. A ratio of the phosphorylated protein band and total protein band was normalized to that of the genotype-
matched mock-infected sample. NS1 was normalized to actin. 200 h simulation (sim) results are shown for PKR phosphorylation (B), eIF2α phosphorylation (C), and inﬂuenza virus
NS1 synthesis (D), in the presence (black line) or absence of P58IPK (grey line). The data are normalized and represented as arbitrary units. Densitometry data derived from the
experimental (exp) results is shown at discrete timepoints with black or grey boxes with standard deviations.
30 A.G. Goodman et al. / Virology 417 (2011) 27–36its two inhibitors, P52rIPK and Hsp40 (Gale et al., 1998; Melville et al.,
1997). However, model predictions show that P58IPK activation is well
approximated by an exponential growth equation (R2=0.99) until
200 h post-infection:
P58a tð Þ = 9:28 1−e−0:168t
 
ð6Þ
revealing an apparent activation rate of 0.168 h−1. This prediction
suggests the apparent rate of P58IPK activation is directly related to the
infectious dose of the virus because the rate for P58IPK activation is
roughly equal to the product of rP58,12 (rate of inﬂuenza virus-mediatedTable 2
Steady-state protein levels.
Parameter P58IPK−⁄− P58IPK+⁄+
P58a
PKRP
eIF2aP
NS1
Value
0
1.89
1.72
29.5
Time (h)
n.a.
5
20
190
Value
9.94
1.51
1.66
44.7
Time (h)
34
56
66
240
As highlighted in the table, in the absence of P58IPK−/−, PKRP initially reaches its steady-
state level by 5 h p.i. However, PKRP slowly increases to 1.92 until 70 h p.i., at which time
it decreases and reaches its steady-state level again by 130 h p.i. (see P58IPK−/− simulated
data in Figs. 3B and 4A).P58IPK activation) and Flu(0) (initial dose of inﬂuenza virus). Further
evidence for this relation between P58IPK activation and infectious dose
is provided in Fig. 5, showing that P58IPK is activated earlier post-
infection when the infectious dose is greater. Additionally, the rate for
PKR activation is roughly three times greater than the P58IPK activation
rate. This suggests that activation of PKR is followed by activation of the
cellular inhibitor of the host defense, P58IPK, allowing the cellular
environment to be better suited for viral replication.Sensitivity of viral protein synthesis to changes in model parameters
The inverse correlation between levels of PKR activation or eIF2α
phosphorylation and viral protein synthesis or replication is well
accepted (Goodman et al., 2007; Smith et al., 2006) and furtherTable 3
Parameters ﬁtted with all biological data.
Symbol Value Covariance (σ2) 95% Conﬁdence interval
[low; high]
rPKR,12,Flu 0.1245 PFU−1h−1 0.0093 [−0.0731; 0.3221]
rP58,12 0.0417 PFU−1h−1 0.0056 [−0.1113; 0.1948]
rP58,21 0.1597 h−1 1.16 [−2.0464; 2.3658]
reIF2α,12 0.0790 nM−1h−1 0.0021 [−0.0152; 0.1732]
reIF2α,21 0.0184 h−1 0.0001 [0.0019; 0.0348]
Parameters were determined by the Levenberg–Marquardt optimization algorithm
described in the Methods section.
Fig. 4. Prediction intervals for simulated PKR and eFI2α phosphorylation and NS1
synthesis show overlap with biological data. 200 h simulation (sim) results are shown
for PKR phosphorylation (A), eIF2α phosphorylation (B), and inﬂuenza virus NS1
synthesis (C), in the presence (black line) or absence of P58IPK (grey line), using the
parameter set generated from ﬁtting simulated data with all biological data. At the
timepoints where experimental data exists, prediction intervals for the simulated data
are shown. Experimental (exp) data are represented with black or grey boxes. Only
single direction prediction intervals are shown in panel B.
Fig. 5. P58IPK reaches maximal, steady-state activation levels faster with increasing
infectious dose. 200 h simulation results are shown for P58IPK activation upon infection
with 0.01, 0.1, 1, 10, or 100 PFU of virus. P58IPK activation reaches steady-state at 180,
150, 120, 80, or 2 h, respectively.
Table 4
Model parameters signiﬁcantly correlated with NS1 synthesis.
Parameter Correlation Coefficient
10 h post-infection 120 h post-infection
rPKR,12,Flu
rPKR,21,P58
rPKR,21,NS1
reIF2   ,12
reIF2   ,21
rFlu
rNS1
K
PKR_total
eIF2   _total
Flu(0)
P58IPK−⁄−
n.s.
n.s.
n.s.
−0.59
n.s.
0.41
0.88
n.s.
−0.72
0.88
0.83
P58IPK+⁄+
n.s.
n.s.
n.s.
n.s.
n.s.
0.44
0.88
n.s.
n.s.
0.88
0.85
P58IPK−⁄−
n.s.
n.s.
−0.59
−0.69
0.66
0.47
0.73
0.62
−0.87
0.73
n.s.
P58IPKIPK+⁄+
−0.52
0.37
−0.55
−0.69
0.62
n.s.
0.75
0.44
−0.87
0.76
n.s.
α
α
α
Two thousand simulation runswere performed using different sampled parameter values
ranging from 25 to 175%. PRCC values determined to be signiﬁcant (Pb10−70) are shown.
n.s., not signiﬁcant. Highlighted data is discussed further in the text.
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affect viral growth kinetics in the presence and absence of P58IPK
remains unclear. To further understand the relationship between
these cellular processes and viral growth kinetics, we performed a
sensitivity analysis to determine the correlation between the cellular
processes represented in our model and NS1 protein synthesis
(Table 4). This analysis showed that the parameters rFlu and K were
more strongly correlated with NS1 synthesis in the absence of P58IPK
at 120 h, suggesting viral replication may be more sensitive to
inﬂuenza virus levels within the cell when P58IPK is absent. The rate of
P58IPK-mediated PKR inhibition (rPKR,21,P58) was also positively
correlated with NS1 synthesis, but only at late times post-infection.
Since PKR activation does not reach steady-state until ~80 h post-
infection, modifying the rate of P58IPK-mediated PKR inhibition will
alter the time at which PKR reaches steady-state, thus affecting levels
of NS1 synthesis.
Other parameters were negatively correlated with NS1 synthesis,
namely reIF2α,12, PKR_total, and rPKR,12,Flu, which correspond to processes
that promote eIF2α phosphorylation. At early times post-infection, the
absence of P58IPK results in a negative correlation for reIF2α,12 and
PKR_total because PKR has reached a level of steady-state activation.
Therefore, variations in total PKR or the rate of PKR-mediated eIF2α
phosphorylation will impact NS1 synthesis to a greater extent in the
absence of P58IPK. However, at late times post-infection the inﬂuenza
virus-mediated PKR activation rate, rPKR,12,Flu, had a negative correlation
with NS1 synthesis in the presence of P58IPK. Nevertheless, these two
correlations, one at early times post-infection in the absence of P58IPK
and the other at late times in the presence of P58IPK, are consistent in
showing that levels of PKR and eIF2α phosphorylation are negatively
correlated to viral protein synthesis.
Enhanced PKR expression in cells lacking P58IPK inhibits viral replication
One of themajor conclusions from our sensitivity analysis was that
NS1 synthesis is particularly sensitive to parameters of the model
pertaining to PKR activation and its downstream effects: reIF2α,12,
PKR_total, and rPKR,12,Flu. To test the validity of our hypotheses, and also
to determine the wider applicability of our model, we took advantage
of a recombinant vaccinia virus system that expresses wild-type PKR
(VVPKR), or a catalytically inactive PKR mutant (K296R) (Lee and
Esteban, 1993). This K296R PKR mutant also acts as a dominant
negative for eIF2α phosphorylation (Gil et al., 2001), serving as a
negative control for the effects of wild-type PKR over-expression.
While these experiments do not utilize inﬂuenza virus, per se, vaccinia
32 A.G. Goodman et al. / Virology 417 (2011) 27–36virus represents another tool for perturbing the P58IPK pathway and
studying the downstream effects of P58IPK activation. Inﬂuenza and
vaccinia virus are remarkably different viruses, but they also share
their similarities with respect to the host response. Similar to
inﬂuenza virus, vaccinia virus activates PKR via dsRNA intermediates
that are part of its viral replication cycle, and like inﬂuenza virus NS1,
vaccinia virus E3L binds dsRNA, resulting in PKR inhibition. Addition-
ally, vaccinia virus K3L inhibits PKR-mediated eIF2α phosphorylation
(Davies et al., 1993; Lee et al., 1994a). Therefore, this experimental
design represents a self-contained viral infection system to test theFig. 6. Over-expression of wild-type PKR during infection in cells lacking P58IPK results in incre
P58IPK+/+ MEFs were mock-infected (M) or infected with recombinant strains of vaccinia vi
increasing MOIs of 0.1, 1, and 10 PFU/cell for 8 h. (A) The levels of phosphorylated PKR and e
densitometry analysis showing the relative levels of phosphorylated PKR and phosphorylated
infected with 1 PFU/cell was measured in triplicate. Standard deviations and P-values from a tw
infected with 1 PFU/cell were stained with annexin V-FITC and propidium iodide and analyzed
positive for annexin V and/or propidium iodide.effects of PKR over-expression on virus replication in the presence and
absence of P58IPK, using the same experimental conditions as previous
experiments used to derive the mathematical model.
In this vaccinia virus system we tested the prediction of the model
that certain cellular processeswere inversely related to viral replication,
particularly in the presence or absence of P58IPK. The activation state of
PKR and eIF2α was determined in P58IPK−/− and P58IPK+/+ MEFs
infected with the VVPKR or K296R strains of vaccinia virus, showing
greatest PKR and eIF2α phosphorylation during VVPKR infection in
P58IPK−/−MEFs (Fig. 6A, lanes 3 and 4 compared to 1). PKR and eIF2αased eIF2α phosphorylation and apoptosis and decreased viral replication. P58IPK−/− and
rus which express wild-type PKR (VVPKR) or a catalytically inactive mutant (K296R) at
IF2α, total PKR and eIF2α, and actin were determined by immunoblot analysis. Data for
eIF2α are provided, which is represented numerically. (B) Infectious virus present in cells
o-tailed Student's t-test assuming non-equal variance are indicated (*, Pb0.05). (C) Cells
by ﬂow cytometry. Percentages represent the fraction of the total cell population that is
33A.G. Goodman et al. / Virology 417 (2011) 27–36phosphorylation in P58IPK+/+ MEFs or during K296R infection were
similar to that of mock infection (Fig. 6A, lanes 6–8 compared to 5, 10–
12 compared to 9, or 14–16 compared to 13). Increased PKR and eIF2α
phosphorylation during VVPKR infection in P58IPK−/− MEFs was
correlated to decreased viral replication, as compared to infection in
P58IPK+/+ MEFs (Fig. 6B, t-test 1). Infection with K296R, which
expresses non-phosphorylateable PKR, in P58IPK−/− MEFs resulted in
increased viral replication, as compared to VVPKR infection (Fig. 6B, t-
test 2). It should benoted thatwe also performed infectionswith awild-
type strain of vaccinia virus (WR); however,we observed nodifferences
in PKR activation, eIF2α phosphorylation, or viral replication between
P58IPK−/− and P58IPK+/+ MEFs (data not shown). While WR infection
resulted in slightly increased levels of viral replication anddecreased PKR
and eIF2α phosphorylation, no differences were observed in P58IPK−/−
and P58IPK+/+ MEFs, like K296R infection. Therefore, K296R infection
was pursued as a control, since it over-expresses total PKR, as does
VVPKR. Together, these results corroborate the sensitivities predicted by
the model, showing that viral replication becomes more sensitive to
increased levels of activated PKR in the absence of P58IPK.
Prior studies showover-expression ofwild-type PKR during vaccinia
virus infection results in increased apoptosis as compared to expression
of PKR containing the K296R mutation (Lee and Esteban, 1994).
Furthermore, P58IPK is anti-apoptotic, due to its inhibitory effects on
PKR (Tang et al., 1999). To establish whether levels of apoptosis are
enhanced in the presence of PKR and absence of P58IPK, we performed
ﬂow cytometry on cells infected with VVPKR and K296R (Fig. 6C). We
observed the greatest number of cells positive for apoptosis in the
presence ofwild-typePKRover-expression inP58IPK−/−MEFs (19.1%, as
compared to 5.0% in P58IPK+/+MEFs). Infection with K296R resulted in
increased apoptosis as compared to mock infection and the greatest
levels of apoptosis resulted in the least amountof viral replication. These
results support the inverse correlation between PKR over-expression
and viral replication in the absence of P58IPK, as predicted by the
sensitivity analysis of the mathematical model, showing how the
analysis of a model can lead to novel experimental designs and results.
Discussion
This study integrated computational and experimental analyses to
predict and elucidate kinetic interactions within the P58IPK pathway,
which we had previously investigated only experimentally (Goodman
et al., 2007). After establishing kinetic parameters that predicted
measured biological behavior in the presence and absence of P58IPK, we
used this model to probe kinetic interactions within the P58IPK pathway
and identify protein interactions that confer viral replication. Strengths of
this model aremulti-faceted: it predicts that P58IPK is rapidly activated in
response to inﬂuenza virus infection but dependent on infectious dose, it
simulates long-termviral infection kinetics, and it correlates variedmodel
parameters with viral protein synthesis. Model analyses, in combination
with corroborative experimental results, identify favorable targets within
the P58IPK pathway for counteracting virus infection.
Although empirical data from previous inﬂuenza virus infection
experiments was useful for guiding model formulations and param-
eter optimization, the generation of a test set of biological data was
necessary to examine the validity of the model. However, a scarcity of
published data from other viral infection models interrogating the
P58IPK pathway remains, highlighting a need for more viral infection
experiments perturbing the P58IPK pathway. To validate the conclu-
sions drawn from themodel analyses and to instill more conﬁdence in
the model structure, we performed experiments with vaccinia virus,
which, like inﬂuenza virus, is particularly sensitive to translational
control, eIF2α phosphorylation, and innate immune responses
(Garcia et al., 2007). Greater similarity between inﬂuenza and
vaccinia viruses exists in the host range genes they encode to inhibit
the anti-viral response. Inﬂuenza virus NS1 is necessary for replication
in wild-type mice, but is dispensable for replication in mice lackingPKR (Bergmann et al., 2000). Similarly, vaccinia virus lacking E3L only
produced lethal disease in mice lacking PKR and replicated to higher
titers than in wild-type mice (Rice et al.), providing further evidence
that E3L is a critical host range protein necessary for efﬁcient viral
replication (Beattie et al., 1996; Langland and Jacobs, 2002). Taken
together, mutant inﬂuenza and vaccinia viruses are useful tools to
study the PKR anti-viral pathway.
As the absence of P58IPK had no effect on the replication of vaccinia
virus lackingE3L (datanot shown), the experimental designwepursued
in this study made use of a recombinant vaccinia virus expressing PKR,
andwedescribed that the absence of P58IPK had aprofoundeffect on the
replication of this virus due to increased levels of PKR and eIF2α
phosphorylation. Model predictions showed that at early times post-
infection, viral protein synthesis was particularly sensitive to levels of
PKR and the rate of PKR activation when P58IPK was absent. Taking
advantage of the experimental design derived from the analysis of the
model, we also showed that levels of apoptosis were enhanced during
infectionwhen PKRwas over-expressed in the absence of P58IPK. Future
studies could take advantage of other recombinant vaccinia viruses
expressing mutant eIF2α (Gomez et al., 2005) to explore the model's
sensitivities to the rate of eIF2α phosphorylation and its role in viral
protein synthesis and virulencewith respect to P58IPK. Additionally, the
role of NS1-mediated PKR inhibition in the context of P58IPK could be
further studied and modeled using inﬂuenza viruses containing
mutations in NS1 that reduces the protein's ability to bind dsRNA and
inhibit PKR (Hatada et al., 1999; Min et al., 2007).
This modeling effort facilitated identifying potential targets for
intervening against viral replication by probing the correlation
between NS1 synthesis and rate values or protein concentrations in
the P58IPK pathway during infection. Current inﬂuenza virus thera-
peutics consist of anti-viral drugs that inhibit the virus’ ion channel
and neuraminidase. Interferon treatment has also been proposed as
an adjuvant for these drugs (Bracci et al., 2005). If a drug could be
discovered that acted speciﬁcally on a cellular protein involved in the
response against infection, treatment of the infection could be
improved. For example, Budd, et al. have demonstrated that
modulating the host cytokine response with an anti-inﬂammatory
agent affects the outcome to inﬂuenza virus infection (Budd et al.,
2007). Our analysis suggested that at early times post-infection,
heightened levels of total PKR would decrease levels of NS1 synthesis,
especially when P58IPK is absent and not inhibiting PKR activation.
The down-regulation of P58IPK would allow for a quicker and more
robust PKR-mediated response at the onset of infection to curb viral
replication. To further test this hypothesis, one could transiently
downregulate P58IPK via siRNA and induce PKR expression prior to
virus infection. This could also be tested in animals with the use of
intranasal siRNAs (Sioud and Barik, 2009). Late in infection, our
analysis predicted that to reduce viral replication, it would be most
prudent to heighten PKR sensitivity, particularly when P58IPK is fully
activated to regulate PKR hyperactivation, for this too is detrimental
to the host (Goodman et al., 2009). Experimentally, one could boost
PKR activation with dsRNA as the infection continues. These methods
could be used in conjunction with established anti-viral compounds
to decrease the overall burden of the virus.
Understanding how cellular proteins affect viral infection is important
for gaining better insight about therapeutic targets. Using mathematical
modeling to test themental picture of these cellular pathways allows one
to develop and perturb the network dynamics describing a signaling
pathway in silico, complementing the interpretation of biological
experiments. In this study, we were able to develop a straightforward
mathematical model to study how the P58IPK pathway is associated with
virus infection. This model offers signiﬁcant insight about the kinetics of
protein interactions downstream of P58IPK, even in its absence, providing
an opportunity to simulate a speciﬁc metabolic signaling pathway during
viral infection in a mammalian cell culture system. Future computational
studies could expand the model's scope to include other molecules that
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signiﬁcance would be MK2 and MK3, two MAPKAPKs which form a
multimeric protein complex with P58IPK to inhibit PKR (Luig et al., 2010)
or proteins of the unfolded protein response which are up-regulated
during coxsackievirus infection due to P58IPK inhibition (Zhang et al.,
2010). Together, our work shows that the merging of qualitative
laboratory datawith quantitativemodeling data can allow the researcher
to uncover coordinated behavior between molecules or identify
structures of burgeoning molecular networks. From this, new experi-
ments can be designed to discover novel mechanisms for the designing
and evaluation of therapeutics for potential future viral pandemics.
Methods
Parameter derivation and simulation procedures
Transition rates and relative, initial concentration values were
based upon our experimental measurements, all gathered under
identical experimental conditions (Goodman et al., 2007), published
literature values, and optimization techniques (Table 1). Prior studies
reported that inﬂuenza virions are produced by 12 h post-infection
(Borland and Mahy, 1968), supporting our empirical measurements
(Goodman et al., 2007) and the mathematics describing logistical
inﬂuenza virus growth (Eq. 4) with a growth rate (rFlu) of 0.075 h−1.
NS1 is highly abundant at early times post-infection, but appears
relatively dynamic (Lamb et al., 2001), leading us to scale the NS1
growth rate (rNS1) at two-thirds the value of rFlu. We derived a
carrying capacity (K) of 100 PFU for inﬂuenza virus within a cell based
on the observation that 105 mouse embryo ﬁbroblasts release 107
PFU/ml at 24 h post-infection (Goodman et al., 2010). The rate
constant for P58IPK-mediated PKR inhibition (rPKR,21,P58) was derived
from Fig. 3B of Lee et al.(1994b), which portrayed a titration of the
molar ratio between of PKR and P58IPK needed to achieve PKR
inhibition in 10 min. Similarly, the rate constant for NS1-mediated
PKR inhibition (rPKR,21,NS1) was derived from Fig. 5 of Lu et al.(1995),
which described the amount of NS1 needed to inhibit PKR in 15 min.
Because NS1 inhibits PKR phosphorylation by 24 h p.i during an
infection at 2 PFU/ml (Bergmann et al., 2000) but P58IPK inhibits PKR
phosphorylation by 8 h post-infection during an infection at 1 PFU/ml
(Goodman et al., 2007), rPKR,21,P58 was greater than rPKR,21,NS1. While
half of the parameter values (rPKR,21,P58, rPKR,21,NS1, rFlu, rNS1, and K)
were derived from the literature (Borland and Mahy, 1968; Goodman
et al., 2010; Lamb et al., 2001; Lee et al., 1994b; Lu et al., 1995), a
weighted, non-linear least squares optimization algorithm was used
to derive the remaining parameter values (rPKR,12,Flu, rP58,12, rP58,21,
reIF2α,12, and reIF2α,21).
All computation was performed in Matlab (v7.1, The Mathworks,
Natick, MA.), using stiff, numerical integration (ode15s.m) to solve
the system of differential equations. Curve ﬁtting of numerical data
derived from the modeled P58IPK activation was performed with the
Curve-Fitting Toolbox built in to Matlab, and sample correlation was
performed with the corrcoef.m function. To optimize the ﬁve
unknown parameters (rPKR,12,Flu, rP58,12, rP58,21, reIF2α,12, and reIF2α,21),
we applied an unconstrained non-linear minimization (fminsearch.m,
implementing a Nelder–Mead simplex algorithm) to minimize the
sum-squared residuals for the biological data obtained in the presence
or absence of P58IPK using the weighted error function:
∑
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where “data” and “sim” refer to values calculated from biological and
simulated experiments respectively, and σ refers to the standarddeviation of a speciﬁc biological data point. Because there was no
standard deviation data published for PKR phosphorylation at 8 h post-
infection, we implemented a standard error of 10% for this pair of data
points. Parameters derived from the literature, namely rPKR,21,P58, rPKR,21,
NS1, rFlu, rNS1, andK,wereﬁxed for all simulations, and thus excluded from
the parameter estimation. The remaining ﬁve unknown parameters
were estimated using the training set of data consisting of previously
published infection results from early timepoints post-infection in the
presence or absence of P58IPK (Goodman et al., 2007). To ﬁt themodel to
all biological data and re-derive the ﬁve unknown parameter values, we
used the nlinﬁt.m function, which uses the Levenberg–Marquardt
algorithm for nonlinear least squares to compute non-robust ﬁts. Fitting
results were passed to the nlparci.m function to calculate parameter
covariances and conﬁdence intervals and to the nlpredci.m function to
calculateparameter intervals. Finally, all parameter valueswere identical
whether simulating the P58IPK−/− or wild-type (P58IPK+/+) conditions,
except for the parameter representing P58IPK concentration in the
cell, which was set P58_total= 0 to simulate P58IPK−/−. The model can
be found at the “JWS Online Cellular Systems Modelling” database
(http://www.jjj.bio.vu.nl).
While our model describes proteins downstream from P58IPK that
are involved in inﬂuenza virus infection, it was not possible to include
all proteins related to virus infection and the P58IPK pathway. Besides
PERK, other eIF2α kinases, namely HRI and GCN2, were also excluded
from the model, as they have not been shown to be activated during
inﬂuenza virus infection or inhibited by P58IPK (Berlanga et al., 2006;
Lee et al., 1994b). Even though inﬂuenza virus hemagglutinin (HA) is
highly glycosylated and can induce ER stress in a virus-free system
(Braakman et al., 1991; Galli et al., 2011), infection with inﬂuenza
virus has not been shown to induce ER stress or an unfolded protein
response. Recently, Luig et al. showed that the mitogen-activated
protein kinase-activated protein kinases (MAPKAPKs) MK2 and MK3
were activated upon inﬂuenza virus infection, forming a part of the
complex which inhibits PKR along with P58IPK (Luig et al., 2010). As
MK2 and MK3 activation are upstream of P58IPK-mediated PKR
inhibition, these molecules were excluded from our current model.
However, they represent sound directions for expanding the model to
include a subsequent level of signaling in the future.
Sensitivity analysis
The goal of sensitivity analysis is to correlate variances in parameter
values to variances inmodel output and is useful when parameter values
are not knownwith certainty. Sampling-based sensitivity analysis entails
specifying a distribution for each parameter from which values are
selected at random and used in model simulations (Chang et al., 2005;
Helton and Davis, 2001). In particular, non-zero parameters were varied
byassigninguniformdistributions ranging from25% to175%of respective
baseline values and sampling 2000 values from these distributions by
Latin Hypercube Sampling. Runs were generated for random combina-
tions of these parameter values, with the output chosen to be NS1
concentrations at timepoints 10 h and 120 h. The sensitivity of the output
to variation in each parameterwas determined bypartial rank correlation
coefﬁcients (PRCC) values varying between−1 and 1, corresponding to
perfect negative and positive correlations, respectively. P-values were
assigned to each PRCC value following the method of Blower and
Dowlatabadi (Blower and Dowlatabadi, 1994) and Bonferroni-corrected
for the number of samplings.
Cells, viruses, and infections
Mouse embryo ﬁbroblasts (MEFs) derived fromwild-type C57BL/6
(P58IPK+/+) mice or mice lacking Dnajc3, the gene for P58IPK
generated on the C57BL/6 background (P58IPK−/−) were grown as
previously described (Goodman et al., 2007; Ladiges et al., 2005). BSC-
40 monkey kidney epithelial cells were grown as monolayers in
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(hgDMEM) supplemented to contain 2 mM L-glutamine, 0.1 mM
nonessential amino acids, Fungizone Amphotencin B (0.5 μg/ml),
penicillin G (100 units/ml), streptomycin sulfate (100 μg/ml) and 10%
newborn calf serum (NCS) (Sigma). Wild-type vaccinia virus (strain
WR) and recombinant viruses expressing wild-type PKR (VVPKR) or
its catalytically inactive mutant (K296R) were grown onmonkey BSC-
40 cells, puriﬁed by a 45% (w/v) sucrose cushion, and titrated on BSC-
40 cells by plaque assay. The A/WSN/33 (WSN) strain of inﬂuenza
virus was grown in Madin–Darby bovine kidney cells as previously
described (Etkind and Krug, 1975).
Near-conﬂuent monolayers of cells were mock-infected or infected
with vaccinia virus diluted in supplemented hgDMEM to the indicated
multiplicity of infection (MOI). After 1 h of adsorption at 37 °C, virus and
medium was removed. Fresh supplemented hgDMEM containing 2%
NCS was added to the cells and infections were allowed to proceed at
37 °C until the indicated time post-infection. Recombinant viruses
express wild-type PKR or its mutant form under regulated control of an
isopropyl β-D-1-thiogalactopyranoside (IPTG) inducible promoter at
1.5 mM, as previously described (Lee and Esteban, 1993). Inﬂuenza
virus infections in P58IPK−/− and P58IPK+/+ MEFs were performed as
previously described (Goodman et al., 2007).
Protein analyses and plaque assays
Protein and immunoblot analyses were performed as previously
described (Goodman et al., 2010) using primary antibodies for
inﬂuenza virus NS1 (a kind gift from Adolfo García-Sastre), total
PKR, total eIF2α (Santa Cruz Biotechnology), pT451 PKR, pS52 eIF2α
(Invitrogen), or actin (MP Biomedicals).
At the indicated times post-infection, infected cells and cell media
supernatant were collected and assayed in triplicate for viral yield by
standard plaque assay on BSC-40 cells. Viral yields were calculated
according to the formula: log10 yieldt=x=[log10(PFU/ml)t=x]−
[log10(PFU/ml)t=0], where t is time and x is the time post-infection.
Flow cytometry analysis
At the indicated times post-infection, cells were collected via
trypsinization, resuspended in 1× annexin V Binding Buffer, stained
with 10 μL/106 cells of annexin V-FITC and propidium iodide according
to the manufacturer's instructions (Beckman Coulter). Flow cytometry
was performed with the LSR II System (BD Biosciences) and data was
analyzed with BD FACSDiva Software v. 6.1.
Acknowledgments
We thank Dr. Kalyan C. Vinnakota for advice regarding parameter
optimization techniques. We also thank Maria del Carmen Moreno-
Ortiz Navarro and Sara Escudero García and the Flow Cytometry Core
Facility at the Centro Nacional de Biotecnología for cytometric
services.
This work was supported by the Ministry of Science and Education
of Spain Program JAE-DOC (CSIC-FSE) (to A.G.G.), the National
Science Foundation Postdoctoral Fellowship in Biology DBI-0905830
(to B.C.W.T.), the Marcelino Botín Foundation (to M.E.), and federal
funding from the National Institute of Allergy and Infectious Diseases,
National Institutes of Health, Department of Health and Human
Services under contract number HHSN272200800060C, and Public
Health Service grants R01AI022646 and U54AI081680 (to M.G.K.).
References
Beattie, E., Kauffman, E.B., Martinez, H., Perkus, M.E., Jacobs, B.L., Paoletti, E., Tartaglia, J.,
1996. Host-range restriction of vaccinia virus E3L-speciﬁc deletion mutants. Virus
Gene 12 (1), 89–94.Bergmann, M., García-Sastre, A., Carnero, E., Pehamberger, H., Wolff, K., Palese, P.,
Muster, T., 2000. Inﬂuenza virus NS1 protein counteracts PKR-mediated inhibition
of replication. J. Virol. 74 (13), 6203–6206.
Berlanga, J.J., Ventoso, I., Harding, H.P., Deng, J., Ron, D., Sonenberg, N., Carrasco, L., de
Haro, C., 2006. Antiviral effect of the mammalian translation initiation factor 2
[alpha] kinase GCN2 against RNA viruses. EMBO J. 25 (8), 1730–1740.
Blower, S.M.,Dowlatabadi, H., 1994. Sensitivity anduncertainty analysis of complexmodels
of disease transmission: an HIV model, as an example. Int. Stat. Rev. 62 (2), 229–243.
Borland, R., Mahy, B.W.J., 1968. Deoxyribonucleic acid-dependent ribonucleic acid
polymerase activity in cells infected with inﬂuenza virus. J. Virol. 2 (1), 33–39.
Braakman, I., Hoover-Litty, H., Wagner, K.R., Helenius, A., 1991. Folding of inﬂuenza
hemagglutinin in the endoplasmic reticulum. J. Cell Biol. 114 (3), 401–411.
Bracci, L., Canini, I., Puzelli, S., Sestili, P., Venditti, M., Spada, M., Donatelli, I., Belardelli, F.,
Proietti, E., 2005. Type I IFN is a powerful mucosal adjuvant for a selective intranasal
vaccination against inﬂuenza virus in mice and affects antigen capture at mucosal
level. Vaccine 23 (23), 2994–3004.
Budd, A., Alleva, L., Alshariﬁ, M., Koskinen, A., Smythe, V., Mullbacher, A., Wood, J., Clark, I.,
2007. Increased survival after gemﬁbrozil treatment of severe mouse inﬂuenza.
Antimicrob. Agents Chemother. 51 (8), 2965–2968.
Chang, S.T., Linderman, J.J., Kirschner, D.E., 2005. Multiple mechanisms allow
Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen
presentation by macrophages. Proc. Natl. Acad. Sci. USA 102 (12), 4530–4535.
Davies, M.V., Chang, H.W., Jacobs, B.L., Kaufman, R.J., 1993. The E3L and K3L vaccinia virus
gene products stimulate translation through inhibition of the double-stranded RNA
dependent protein kinase by different mechanisms. J. Virol. 67, 1688–1692.
Dever, T.E., 2002. Gene-speciﬁc regulation by general translation factors. Cell 108 (4),
545–556.
Dey, M., Cao, C., Dar, A.C., Tamura, T., Ozato, K., Sicheri, F., Dever, T.E., 2005. Mechanistic
link between PKR dimerization, autophosphorylation, and eIF2[alpha] substrate
recognition. Cell 122 (6), 901–913.
Etkind, P.R., Krug, R.M., 1975. Puriﬁcation of inﬂuenza viral complementary RNA: its
genetic content and activity in wheat germ cell-free extracts. J. Of Virol. 16,
1464–1475.
Gale Jr.,M., Blakely, C.M., Hopkins, D.A., Melville, M.W.,Wambach,M., Romano, P.R., Katze,
M.G., 1998. Regulation of interferon-induced protein kinase PKR: modulation of P58
IPK inhibitory function by a novel protein, P52rIPK. Mol. Cell. Biol. 18, 859–871.
Galli, C., Bernasconi, R., Soldà, T., Calanca, V., Molinari, M., 2011. Malectin participates in
a backup glycoprotein quality control pathway in the mammalian ER. PLoS One 6
(1), e16304.
Garcia, M.A., Meurs, E.F., Esteban, M., 2007. The dsRNA protein kinase PKR: virus and
cell control. Biochimie 89 (6–7), 799–811.
Garﬁnkel, M.S., Katze, M.G., 1992. Translational control by inﬂuenza virus: selective and
cap-dependent translation of viral mRNAs in infected cells. J. Biol. Chem. 267,
9383–9390.
Gil, J., Rullas, J., García, M.A., Alcamí, J., Esteban, M., 2001. The catalytic activity of
dsRNA-dependent protein kinase, PKR, is required for NF-kB activation. Oncogene
20 (3), 385–394.
Gomez, C.E., Vandermeeren, A.M., Garcia, M.A., Domingo-Gil, E., Esteban, M., 2005.
Involvement of PKR and RNase L in translational control and induction of
apoptosis after Hepatitis C polyprotein expression from a vaccinia virus
recombinant. Virol. J. 2, 81.
Goodman, A.G., Smith, J.A., Balachandran, S., Perwitasari, O., Proll, S.C., Thomas, M.J.,
Korth, M.J., Barber, G.N., Schiff, L.A., Katze, M.G., 2007. The cellular protein P58IPK
regulates inﬂuenza virus mRNA translation and replication through a PKR-
mediated mechanism. J. Virol. 81 (5), 2221–2230.
Goodman, A.G., Fornek, J.L., Medigeshi, G.R., Perrone, L.A., Peng, X., Dyer, M.D., Proll, S.C.,
Knoblaugh, S.E., Carter, V.S., Korth, M.J., Nelson, J.A., Tumpey, T.M., Katze, M.G.,
2009. P58(IPK): a novel "CIHD" member of the host innate defense response
against pathogenic virus infection. PLoS Pathog. 5 (5), e1000438.
Goodman, A.G., Zeng, H., Proll, S.C., Peng, X., Cilloniz, C., Carter, V.S., Korth,M.J., Tumpey, T.M.,
Katze, M.G., 2010. The alpha/beta interferon receptor provides protection against
inﬂuenza virus replication but is dispensable for inﬂammatory response signaling.
J. Virol. 84 (4), 2027–2037.
Hatada, E., Saito, S., Fukuda, R., 1999.Mutant inﬂuenza viruseswith a defective NS1 protein
cannot block the activation of PKR in infected cells. J. Virol. 73 (3), 2425–2433.
Helton, J.C., Davis, F.J., 2001. Sampling-based methods. In: Saltelli, A., Chan, K., Scott, E.M.
(Eds.), Sensitivity Analysis. Wiley, New York, pp. 101–153.
Ladiges, W.C., Knoblaugh, S.E., Morton, J.F., Korth, M.J., Sopher, B.L., Baskin, C.R.,
MacAuley, A., Goodman, A.G., LeBoeuf, R.C., Katze, M.G., 2005. Pancreatic beta-cell
failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum
molecular chaperone gene P58IPK. Diabetes 54 (4), 1074–1081.
Lamb, R.A., Krug, R.M., Knipe, D.M., Howlet, P.M., Grifﬁn, D.E., Martin, M.A., Roizman, B.,
Straus, S.E., 2001. Orthomyxoviridae: the viruses and their replication. Fields
virology. Lippincott Williams & Wilkins, Philadelphia, PA, pp. 1487–1532.
Langland, J.O., Jacobs, B.L., 2002. The role of the PKR-inhibitory genes, E3L and K3L, in
determining vaccinia virus host range. Virology 299 (1), 133–141.
Lee, S.B., Esteban, M., 1993. The interferon-induced double-stranded RNA-activated human
p68proteinkinase inhibits the replicationof vacciniavirus.Virology193(2), 1037–1041.
Lee, S.B., Esteban, M., 1994. The interferon-induced double-stranded RNA-activated
protein kinase induces apoptosis. Virology 199, 491–496.
Lee, T.G., Tomita, J., Hovanessian,A.G., Katze,M.G., 1992. Characterization and regulationof
the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated
protein kinase. J. Biol. Chem. 267, 14238–14243.
Lee, S.B., Green, S.R., Mathews, M.B., Esteban, M., 1994a. Activation of the double-
stranded RNA (dsRNA)-activated human protein kinase in vivo in the absence of its
dsRNA binding domain. Proc. Natl. Acad. Sci. USA 91, 10551–10555.
36 A.G. Goodman et al. / Virology 417 (2011) 27–36Lee, T.G., Tang, N., Thompson, S., Miller, J., Katze, M.G., 1994b. The 58,000-dalton cellular
inhibitor of the interferon-induced double-stranded RNA-activated protein kinase
(PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol.
14, 2331–2342.
Liu, C.Y., Kaufman, R.J., 2003. The unfolded protein response. J. Cell Sci. 116 (Pt 10),
1861–1862.
Lu, Y., Wambach, M., Katze, M.G., Krug, R.M., 1995. Binding of the inﬂuenza virus
NS1 protein to double-stranded RNA inhibits the activation of the protein kinase
that phosphorylates the eIF-2 translation initiation factor. Virology 214 (1),
222–228.
Luig, C., Köther, K., Dudek, S.E., Gaestel, M., Hiscott, J., Wixler, V., Ludwig, S., 2010. MAP
kinase-activated protein kinases 2 and 3 are required for inﬂuenza A virus
propagation and act via inhibition of PKR. FASEB J. 24 (10), 4068–4077.
Melville, M.W., Hansen, W.J., Freeman, B.C., Welch, W.J., Katze, M.G., 1997. The
molecular chaperone hsp40 regulates the activity of P58 IPK, the cellular inhibitor
of PKR. Proc. Natl. Acad. Sci. USA 94, 97–102.
Min, J.-Y., Li, S., Sen, G.C., Krug, R.M., 2007. A site on the inﬂuenza A virus NS1 protein
mediates both inhibition of PKR activation and temporal regulation of viral RNA
synthesis. Virology 363 (1), 236–243.Regoes, R.R., Bonhoeffer, S., 2006. Emergence of drug-resistant inﬂuenza virus:
population dynamical considerations. Science 312 (5772), 389–391.
Rice, A. D., Turner, P. C., Embury, J. E., Moldawer, L. L., Baker, H. V., and Moyer, R. W.,
2011. Roles of Vaccinia Virus Genes E3L and K3L and Host Genes PKR and RNase L
during Intratracheal Infection of C57BL/6 Mice. J. Virol.85(1), 550–567.
Sioud, M., Barik, S., 2009. Treating respiratory viral diseases with chemically modiﬁed,
second generation intranasal siRNAs. In: Walker, J.M. (Ed.), siRNA and miRNA Gene
Silencing:FromBench toBedside,Vol. 487.HumanaPress,NewYork,NY, pp. 331–341.
Smith, J.A., Schmechel, S.C., Raghavan, A., Abelson, M., Reilly, C., Katze, M.G., Kaufman, R.J.,
Bohjanen, P.R., Schiff, L.A., 2006. Reovirus induces and beneﬁts from an integrated
cellular stress response. J. Virol. 80 (4), 2019–2033.
Tang, N.M., Korth, M.J., Gale Jr., M., Wambach, M., Der, S.D., Bandyopadhyay, S.K.,
Williams, B.R.G., Katze, M.G., 1999. Inhibition of double-stranded RNA- and tumor
necrosis factor alpha-mediated apoptosis by tetratricopeptide repeat protein and
cochaperone, P58IPK. Mol. Cell. Biol. 19, 4757–4765.
Zhang, H.M., Ye, X., Su, Y., Yuan, J., Liu, Z., Stein, D.A., Yang, D., 2010. Coxsackievirus B3
infection activates the unfolded protein response and induces apoptosis through
downregulation of p58IPK and activation of CHOP and SREBP1. J. Virol. 84 (17),
8446–8459.
